Correlation Between Gilead Sciences and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gilead Sciences and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gilead Sciences and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gilead Sciences and Myriad Genetics, you can compare the effects of market volatilities on Gilead Sciences and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gilead Sciences with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gilead Sciences and Myriad Genetics.

Diversification Opportunities for Gilead Sciences and Myriad Genetics

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Gilead and Myriad is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Gilead Sciences and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Gilead Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gilead Sciences are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Gilead Sciences i.e., Gilead Sciences and Myriad Genetics go up and down completely randomly.

Pair Corralation between Gilead Sciences and Myriad Genetics

Given the investment horizon of 90 days Gilead Sciences is expected to generate 0.39 times more return on investment than Myriad Genetics. However, Gilead Sciences is 2.55 times less risky than Myriad Genetics. It trades about 0.26 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.1 per unit of risk. If you would invest  9,188  in Gilead Sciences on November 3, 2024 and sell it today you would earn a total of  532.00  from holding Gilead Sciences or generate 5.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Gilead Sciences  vs.  Myriad Genetics

 Performance 
       Timeline  
Gilead Sciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Gilead Sciences and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gilead Sciences and Myriad Genetics

The main advantage of trading using opposite Gilead Sciences and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gilead Sciences position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Gilead Sciences and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk